CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STW 02
Contemporary high-content screening approaches to assess the biological impact of single compounds and complex mixtures in vitro
(1) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (2) British American Tobacco, R&D Centre, Southampton, U.K.
High-content screening (HCS) is an automated image-based screening technology that allows analysing macroscopically the biological impact of single compounds or complex mixtures on cells growing in multi-well culture dishes. The technology involves...